{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:52:28Z","timestamp":1790117548949,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.cgh.2015.06.022","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T14:30:14Z","timestamp":1435847414000},"page":"1946-1954.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial"],"prefix":"10.1016","volume":"13","author":[{"given":"Alan","family":"Bensoussan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Kellow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzannah J.","family":"Bourchier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fahey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Malcolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2015.06.022_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ajg.2009.12.016","article-title":"Practice guideline, irritable bowel syndrome: a global perspective","volume":"11","author":"Quigley","year":"2010","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.06.022_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.gtc.2007.07.002","article-title":"Irritable bowel syndrome: current approach to symptoms, evaluation and treatment","volume":"36","author":"Videlock","year":"2007","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.cgh.2015.06.022_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2036.2003.01456.x","article-title":"The prevalence, patterns and impact of IBS: an international survey of 40,000 subjects","volume":"17","author":"Hungin","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2015.06.022_bib4","series-title":"Rome III: the functional gastrointestinal disorders","article-title":"Design of treatment trials for functional gastrointestinal disorders","author":"Irvine","year":"2006"},{"key":"10.1016\/j.cgh.2015.06.022_bib5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2165\/00019053-200220110-00004","article-title":"Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria","volume":"20","author":"Badia","year":"2002","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.cgh.2015.06.022_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1467-842X.2001.tb00554.x","article-title":"Application of the general health status questionnaire SF36 to patients with gastrontestinal dysfunction: inital validation and validation as a measure of change","volume":"25","author":"Bensoussan","year":"2001","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.cgh.2015.06.022_bib7","first-page":"S227","article-title":"The impact of IBS on absenteeism and work productivity: United States and eight European countries","volume":"98","author":"Hungin","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.06.022_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gtc.2010.12.013","article-title":"The effect of irritable bowel syndrome on health-related quality of life and healthcare expenditures","volume":"40","author":"Agarwal","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.cgh.2015.06.022_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2036.2006.02938.x","article-title":"Systematic review: the efficacy of treatments for IBS\u2014a European perspective","volume":"24","author":"Tack","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2015.06.022_bib10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gut.52.5.671","article-title":"An Asia-Pacific, double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome","volume":"52","author":"Kellow","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2015.06.022_bib11","article-title":"Tegaserod for the treatment of irritable bowel syndrome","volume":"1","author":"Evans","year":"2004","journal-title":"Cochrane Collab"},{"key":"10.1016\/j.cgh.2015.06.022_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2036.2008.03881.x","article-title":"Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome\u2014results of two randomized, placebo-controlled studies","volume":"3","author":"Drossman","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2015.06.022_bib13","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/ajg.2012.255","article-title":"A\u00a012-week randomized controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation","volume":"107","author":"Rao","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.06.022_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00004836-199912000-00009","article-title":"A\u00a0national survey of practice patterns of gastroenterologists with comparison to the past two decades","volume":"19","author":"Russo","year":"1999","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2015.06.022_bib15","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/01.mcg.0000177234.36640.68","article-title":"The incidence of self-prescribed oral complementary and alternative medicine usage: do international variations exist?","volume":"39","author":"Sanders","year":"2005","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2015.06.022_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.gtc.2010.12.005","article-title":"Complementary and alternative medicine for the irritable bowel syndrome","volume":"40","author":"Magge","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.cgh.2015.06.022_bib17","article-title":"Herbal medicines for treatment of irritable bowel syndrome","volume":"1","author":"Lui","year":"2006","journal-title":"Cochrane Database of Syst Rev"},{"key":"10.1016\/j.cgh.2015.06.022_bib18","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/jama.280.18.1585","article-title":"Treatment of irritable bowel syndrome with chinese herbal medicine: a randomized controlled trial","volume":"280","author":"Bensoussan","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2015.06.022_bib19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.coph.2011.09.007","article-title":"Use of natural products in gastrointestinal therapies","volume":"11","author":"Brierley","year":"2011","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.cgh.2015.06.022_bib20","series-title":"Interaction between Chinese herbal medicine and Western medicine","author":"Zhu","year":"1991"},{"key":"10.1016\/j.cgh.2015.06.022_bib21","series-title":"State Pharmacopoeia Commission of the People's Republic of China. Chinese pharmacopoeia","year":"2010"},{"key":"10.1016\/j.cgh.2015.06.022_bib22","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cgh.2007.03.004","article-title":"Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints","volume":"5","author":"Camilleri","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.06.022_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/2050640614555946","article-title":"Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS-C","volume":"3","author":"Camilleri","year":"2015","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.cgh.2015.06.022_bib24","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to\u00a0intestinal transit time","volume":"32","author":"Heaton","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.06.022_bib25","series-title":"A\u00a0quality of life measure for persons with irritable bowel syndrome (IBS-QOL): users manual","author":"Patrick","year":"1997"},{"key":"10.1016\/j.cgh.2015.06.022_bib26","series-title":"User's manual for the SF-36v2 Health Survey","author":"Ware","year":"2007"},{"key":"10.1016\/j.cgh.2015.06.022_bib27","series-title":"Manual for the Depression Anxiety Stress Scales","author":"Lovibond","year":"2004"},{"key":"10.1016\/j.cgh.2015.06.022_bib28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2036.2004.02091.x","article-title":"The validity and accuracy of the Work Productivity and Activity Impairment questionnaire: irritable bowel syndrome version (WPAI: IBS)","volume":"20","author":"Reilly","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2015.06.022_bib29","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/ajg.2011.78","article-title":"Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting Rome III criteria","volume":"106","author":"Hellstr\u00f6m","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.06.022_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0399-8320(06)73160-8","article-title":"Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL)","volume":"30","author":"Amouretti","year":"2006","journal-title":"Gastroent\u00e9rologie Clinique et Biologique"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356515008460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356515008460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:18:01Z","timestamp":1761542281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356515008460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1542356515008460"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2015.06.022","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2015.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}